[Quantitative immunoglobulin determination during long-term cytostatic therapy].
D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis*; D007075:Immunoglobulin M / Q000032:analysis*; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced*; D007166:Immunosuppressive Agents; D007223:Infant; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology; D007945:Leukemia, Lymphoid / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000276:immunology; D008219:Lymphogranuloma Venereum / Q000276:immunology; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D013921:Thrombocytopenia / Q000276:immunology; D013997:Time Factors; D009396:Wilms Tumor / Q000276:immunology
D000970:Antineoplastic Agents; D007106:Immune Sera; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents
Quantitative Immunoglobulin-Bestimmungen im Laufe langdauernder cytostatischer Therapie.